BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Surov A, Pech M, Gessner D, Mikusko M, Fischer T, Alter M, Wienke A. Low skeletal muscle mass is a predictor of treatment related toxicity in oncologic patients. A meta-analysis. Clin Nutr 2021;40:5298-310. [PMID: 34536638 DOI: 10.1016/j.clnu.2021.08.023] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 8.0] [Reference Citation Analysis]
Number Citing Articles
1 Meyer H, Strobel A, Wienke A, Surov A. Prognostic role of low-skeletal muscle mass on staging computed tomography in metastasized colorectal cancer: a systematic review and meta-analysis. Clinical Colorectal Cancer 2022. [DOI: 10.1016/j.clcc.2022.03.005] [Reference Citation Analysis]
2 Prado CM, Orsso CE, Pereira SL, Atherton PJ, Deutz NEP. Effects of β-hydroxy β-methylbutyrate (HMB) supplementation on muscle mass, function, and other outcomes in patients with cancer: a systematic review. J Cachexia Sarcopenia Muscle 2022;13:1623-41. [PMID: 35301826 DOI: 10.1002/jcsm.12952] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]
3 Leão I, Garcia C, Antunes P, Campolargo A, Dias I, Coimbra E, Oliveira P, Zenha H, Costa H, Capela A, Viamonte S, Alves AJ, Joaquim A. Acute Impact of Cancer Treatment on Head and Neck Cancer Patients: FIT4TREATMENT. Cancers (Basel) 2022;14:2698. [PMID: 35681678 DOI: 10.3390/cancers14112698] [Reference Citation Analysis]
4 Meyer H, Wienke A, Surov A. Sarcopenia as a Prognostic Marker for Survival in Gastric Cancer Patients Undergoing Palliative Chemotherapy. A Systematic Review and Meta Analysis. Nutrition and Cancer. [DOI: 10.1080/01635581.2022.2077387] [Reference Citation Analysis]
5 Thormann M, Omari J, Pech M, Damm R, Croner R, Perrakis A, Strobel A, Wienke A, Surov A. Low skeletal muscle mass and post-operative complications after surgery for liver malignancies: a meta-analysis. Langenbecks Arch Surg 2022. [PMID: 35583832 DOI: 10.1007/s00423-022-02541-5] [Reference Citation Analysis]
6 Chang B, Peng T, Wu Y, Hsieh T, Huang C. Prognostic Values of Inflammatory Indexes and Clinical Factors in Patients with Epidermal Growth Factor Receptor Mutations in Lung Adenocarcinoma and Treated with Tyrosine Kinase Inhibitors. JPM 2022;12:404. [DOI: 10.3390/jpm12030404] [Reference Citation Analysis]